Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05376891 · ClinicalTrials.gov registry record
Met Non Small Cell Cancer Registry (MOMENT)
A clinical trial of Cancer, sponsored by EMD Serono Research & Development Institute.
- Recruiting
- Registry status
- 700
- Enrollment target
- 20
- Study locations
NCT05376891: Recruiting study of Cancer, sponsored by EMD Serono Research & Development Institute.
NCT05376891 is a study of Cancer that is actively recruiting participants, run by EMD Serono Research & Development Institute. The registered enrollment target is 700 participants, below the 3,490-participant average among 615 other Cancer trials with a reported enrollment target (80% lower). The trial reports 20 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05376891, a study of Cancer, is actively recruiting participants, sponsored by EMD Serono Research & Development Institute.
- RECRUITING
- Registry status
- 700 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this multi-national disease registry is to collect prospectively (with longitudinal follow-up) high-quality, standardized, and contemporaneous data to capture changes in the non-small cell lung cancer (NSCLC) treatment landscape and outcomes over time. The registry will capture data on participants; demographic, clinical characteristics (including biomarker data), treatment patterns, and effectiveness and safety outcomes for advanced NSCLC with mesenchymal-epithelial transition exon 14 (METex14) participants treated with systemic therapy.
Conditions Studied
Study Locations (20)
Other
- Klinikum Klagenfurt Am Woerthersee - Klagenfurt
- Klinik Floridsdorf - Vienna
- AZ Delta - Roeselare
- AZ Nikolaas - Sint-Niklaas
- Ottawa Hospital General Campus - Ottawa
- Princess Margaret Cancer Centre - Toronto
- FN Olomouc - Olomouc
- University Hospital Na Bulovce - Prague
- Centre Hospitalier de Cholet - Cholet
- CHRU Lille - Lille
- Hôpital du Scorff - Lorient
- Centre Leon Berard - Lyon
- Hospital Tenon & University Paris 6 - Paris
- Institut Curie - Centre de Lutte Contre le Cancer (CLCC) - Paris
- CHU de Toulouse Hopital Larrey - Toulouse
- Klinikum Chemnitz GmbH - Chemnitz
- KKH Grosshansdorf GmbH - Großhansdorf
Florida
- Holy Cross Health - Fort Lauderdale
Ohio
- The Ohio State University Wexner Medical Center - Columbus
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 700 participants |
| Start Date | 2022-10-04 |
| Est. Completion | 2028-04-28 |
What NCT05376891 shows while recruiting
NCT05376891 is an observational study that tracks outcomes without assigning an intervention. The registered 700 participants enrollment target is mid-sized for trials with a published cap, below the 3,490-participant average among 615 other Cancer trials with a reported enrollment target (80% lower).
The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT05376891 names 20 study sites across 4 states, led by Other, Florida, Ohio.
Frequently Asked Questions
What is clinical trial NCT05376891 about?
NCT05376891 is a clinical study titled "Met Non Small Cell Cancer Registry (MOMENT)". The purpose of this multi-national disease registry is to collect prospectively (with longitudinal follow-up) high-quality, standardized, and contemporaneous data to capture changes in the non-small cell lung cancer (NSCLC) treatment landscape and outcomes over time. The registry will capture data ...
What is the current status of trial NCT05376891?
This trial is currently recruiting. The enrollment target is 700 participants. The study started on 2022-10-04. Estimated completion is 2028-04-28.
What conditions does trial NCT05376891 study?
This clinical trial studies the following conditions: Cancer.
Who is sponsoring clinical trial NCT05376891?
This trial is sponsored by EMD Serono Research & Development Institute, which has 81 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05376891 being conducted?
This trial has 20 study locations across Florida, Ohio, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05376891's enrollment target sits among peer trials
700 99th of 615 higher than 515 of 615 other Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated with Radiation
RECRUITING
-
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
RECRUITING · Phase 2
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
RECRUITING · Phase 1
-
Long-Term Follow-Up of Recipient of Gene Transfer Research
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900419 · 700 participants
Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
- NCT01804686 · 700 participants · Phase 3
A Long-term Extension Study of PCI-32765 (Ibrutinib)
- NCT02107989 · 700 participants
Noninvasive Pre-surgical Evaluation of Patients With Focal Epilepsy and Establishment of a Normative Imaging Database
- NCT02576483 · 700 participants
An Evaluation of LASIK, SMILE and PRK Surgery in Physicians
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI